FCGRT and autoimmune disease: Commonly used agents in autoimmune diseases including corticosteroids, rituximab, cyclosporine and sirolimus have been widely available and may be a more cost-effective option, however FcRn inhibitors offer a fast acting, safe steroid-sparing approach and have a role in acute disease management as well as after failure of prior therapies.